To realize their potential, AI technologies need new systems that leverage them. by Ajay Agrawal, Joshua Gans and Avi Goldfarb Investor: “What will your artificial intelligence do for businesses?” ...

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701 ...